Talha Khan Burki. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdenoviridaeBetacoronavirusCOVID-19COVID-19 VaccinesClinical Trials, Phase III as TopicCoronavirus Infections/immunologyCoronavirus Infections/prevention & controlHumansPandemics/prevention & controlPneumonia, Viral/prevention & controlRussiaSARS-CoV-2Viral Vaccines/immunology
Substances: See more » COVID-19 VaccinesViral Vaccines
Year: 2020 PMID: 32896274 DOI: 10.1016/S2213-2600(20)30402-1
Source DB: PubMed Journal: Lancet Respir Med ISSN: 2213-2600 Impact factor: 30.700